Sculptor Capital’s AbbVie ABBV Stock Holding History

Sculptor Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,015,000	Closed	-$327M	–	350
2015 Q3	$327M	Buy	6,015,000 +28,100	+0.5%	+$1.83M	1.14%	24
2015 Q2	$402M	Buy	+5,986,900	New	+$391M	1.17%	26
2015 Q1	–	Sell	-15,600	Closed	-$1.02M	–	389
2014 Q4	$1.02M	Hold	15,600	–	–	﹤0.01%	624
2014 Q3	$901K	Hold	15,600	–	–	﹤0.01%	675
2014 Q2	$880K	Hold	15,600	–	–	﹤0.01%	675
2014 Q1	$802K	Sell	15,600 -264,400	-94%	-$13.4M	﹤0.01%	662
2013 Q4	$14.8M	Sell	280,000 -59,000	-17%	-$2.9M	0.04%	390
2013 Q3	$15.2M	Sell	339,000 -269,600	-44%	-$12M	0.04%	388
2013 Q2	$25.2M	Buy	+608,600	New	+$26.6M	0.08%	291

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sculptor Capital's ABBV Position: Q2 2022 in Review

Sculptor Capital sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 392,858 shares — an estimated $63.7M sold.

Sculptor Capital first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $886M in Q3 2014. 3,006 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Sculptor Capital reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Sculptor Capital sold 392,858 AbbVie shares in Q2 2022, an estimated $63.7M.
Sculptor Capital first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
Sculptor Capital's AbbVie position peaked at $886M in Q3 2014.
3,006 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Sculptor Capital's 13F filing for Q2 2022, filed 12 Aug 2022.